WIXOM, Mich., June 29, 2009 (GLOBE NEWSWIRE) -- Rockwell Medical Technologies, Inc. (Nasdaq:RMTI), a fully-integrated biopharmaceutical company offering innovative products and services targeting end-stage renal disease (ESRD), chronic kidney disease (CKD) and iron deficiency anemia, is pleased to announce that it has been added to the Russell 2000, 2500, 3000 and Global Indexes. Rockwell will also maintain its membership in the Russell Microcap Index.
